Evidence map›Paper›PMID 39654043›Full record

ArticleJournal of cheminformatics2024

Human-in-the-loop active learning for goal-oriented molecule generation.

Yasmine Nahal, Janosch Menke, Julien Martinelli, Markus Heinonen, Mikhail Kabeshov, Jon Paul Janet, Eva Nittinger, Ola Engkvist, Samuel Kaski

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yasmine NahalDepartment of Computer Science, Aalto University, 02150, Espoo, Finland. yasmine.nahal@aalto.fi.
Janosch MenkeDepartment of Computer Science and Engineering, Chalmers University of Technology, 412 96, Gothenburg, Sweden.
Julien MartinelliInserm Bordeaux Population Health, Vaccine Research Institute, Université de Bordeaux, Inria Bordeaux Sud-ouest, 33405, Talence, France.
Markus HeinonenDepartment of Computer Science, Aalto University, 02150, Espoo, Finland.
Mikhail KabeshovMolecular AI, Discovery Sciences, R&D, AstraZeneca, 431 83, Mölndal, Sweden.
Jon Paul JanetMolecular AI, Discovery Sciences, R&D, AstraZeneca, 431 83, Mölndal, Sweden.
Eva NittingerMedicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), R&D, AstraZeneca, 412 96, Gothenburg, Sweden.
Ola Engkvist *Molecular AI, Discovery Sciences, R&D, AstraZeneca, 431 83, Mölndal, Sweden.
Samuel Kaski *Department of Computer Science, Aalto University, 02150, Espoo, Finland.

Funding

Academy of Finland Flagship program: the Finnish Center for Artificial Intelligence FCAIHorizon 2020 956832UKRI Turing AI World-Leading Researcher Fellowship EP/W002973/1
6 · The paper itself

Abstract

Machine learning (ML) systems have enabled the modelling of quantitative structure-property relationships (QSPR) and structure-activity relationships (QSAR) using existing experimental data to predict target properties for new molecules. These property predictors hold significant potential in accelerating drug discovery by guiding generative artificial intelligence (AI) agents to explore desired chemical spaces. However, they often struggle to generalize due to the limited scope of the training data. When optimized by generative agents, this limitation can result in the generation of molecules with artificially high predicted probabilities of satisfying target properties, which subsequently fail experimental validation. To address this challenge, we propose an adaptive approach that integrates active learning (AL) and iterative feedback to refine property predictors, thereby improving the outcomes of their optimization by generative AI agents. Our method leverages the Expected Predictive Information Gain (EPIG) criterion to select additional molecules for evaluation by an oracle. This process aims to provide the greatest reduction in predictive uncertainty, enabling more accurate model evaluations of subsequently generated molecules. Recognizing the impracticality of immediate wet-lab or physics-based experiments due to time and logistical constraints, we propose leveraging human experts for their cost-effectiveness and domain knowledge to effectively augment property predictors, bridging gaps in the limited training data. Empirical evaluations through both simulated and real human-in-the-loop experiments demonstrate that our approach refines property predictors to better align with oracle assessments. Additionally, we observe improved accuracy of predicted properties as well as improved drug-likeness among the top-ranking generated molecules. SCIENTIFIC CONTRIBUTION: We present an adaptable framework that integrates AL and human expertise to refine property predictors for goal-oriented molecule generation. This approach is robust to noise in human feedback and ensures that navigating chemical space with human-refined predictors leverages human insights to identify molecules that not only satisfy predicted property profiles but also score highly on oracle models. Additionally, it prioritizes practical characteristics such as drug-likeness, synthetic accessibility, and a favorable balance between exploring diverse chemical space and exploiting similarity to existing training data.

Indexed as

Active learningGoal-oriented molecule generationHuman-in-the-loopInteractive algorithmsMachine learning

Identifiers

PMID39654043
PMCPMC11629536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.